Saturday, November 18, 2017
Company News: Page (1) of 1 - 09/11/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Results from the INJOURNEY™ trial investigating Ofev® with add-on pirfenidone provide new insights into this combination treatment for IPF
- Data from this 12-week study showed that the safety and tolerability profile of Ofev® (nintedanib) with add-on pirfenidone is in keeping with the known profiles of the individual drugs in patients w...
(September 11, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:USA, Inc.,Medicine,Diet,Disease,Surgery,Pregnancy,Surgery,Medication,Vitamins/Nutrition,Womens Health,Pregnancy,Physician,Health Technologist,Science,Medical,Business,Family,Children,Other,Men,Women,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines